The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: The coexistence predicts a poor prognosis regardless of EGFR levels

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 4, 2008, Pages 439-451

  Tsakiris, Ioannis ^a   Soos, Gyorgyike ^a   Nemes, Zoltan ^a   Kiss, Sandor Sz ^a   Andras, Csilla ^a   Szantó, Janos ^a   Dezso, Balazs ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Carboxypeptidase M; CPM; EGFR; Immunohistochemistry; Lung adenocarcinoma; Survival

Indexed keywords

CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; EPIDERMAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR CELL;

EID: 40049084926     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0304-z     Document Type: Article

References (50)

1. C Blanco-Aparicio MA Molina E Fernandez-Salas 1998 Potato carboxypeptidase inhibitor, a T-knot protein is an epidermal growth factor antagonist that inhibits tumor cell growth J Biol Chem 273 12370 12377 9575190 10.1074/jbc.273.20.12370 1:CAS:528:DyaK1cXjtlSgtLg%3D Blanco-Aparicio C, Molina MA, Fernandez-Salas E et al (1998) Potato carboxypeptidase inhibitor, a T-knot protein is an epidermal growth factor antagonist that inhibits tumor cell growth. J Biol Chem 273:12370–12377
2. E Brambilla WD Travis TV Colby B Y Corrin Shimosato 2001 Histologic typing of tumours of lung and pleura: the new World Health Organization classification of tumours Eur Respir J 18 1059 1068 11829087 10.1183/09031936.01.00275301 1:STN:280:DC%2BD38%2FpvVOqtw%3D%3D Brambilla E, Travis WD, Colby TV, Corrin B Shimosato Y (2001) Histologic typing of tumours of lung and pleura: the new World Health Organization classification of tumours. Eur Respir J 18:1059–1068
3. F Ciardiello 2005 Epidermal growth factor receptor inhibitors in cancer treatment Future Oncol 1 221 234 16555994 10.1517/14796694.1.2.221 1:CAS:528:DC%2BD2MXktlOmtbo%3D Ciardiello F (2005) Epidermal growth factor receptor inhibitors in cancer treatment. Future Oncol 1:221–234
4. AJ Cohen RA Skidgel LB Gilman 1997 Carboxypeptidase M: variable expression in normal human lung and inactivation in lung cancer Chest 11 149S 10.1378/chest.111.6_Supplement.149S Cohen AJ, Skidgel RA, Gilman LB et al (1997) Carboxypeptidase M: variable expression in normal human lung and inactivation in lung cancer. Chest 11:149S
5. S Dacic M Flanagan K Cieply 2006 Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma Am J Clin Pathol 125 860 865 16690485 10.1309/H5UW6CPCWWC92241 1:CAS:528:DC%2BD28XmtVOksLo%3D Dacic S, Flanagan M, Cieply K et al (2006) Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Am J Clin Pathol 125:860–865
6. B Dezso PG Haas F Hamzavi 1996 The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases Clin Cancer Res 2 1543 1552 9816331 1:CAS:528:DyaK28XmtFSrt7c%3D Dezso B, Haas PG, Hamzavi F et al (1996) The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases. Clin Cancer Res 2:1543–1552
7. T Dragovic DE Schraufnagel RP Becker M Sekosan EG Votta-Velis EG Erdős 1995 Carboxypeptidase M activity is increased in bronchoalveolar lavage in human lung disease Am J Respir Crit Care Med 152 760 764 7633739 1:STN:280:DyaK2MzmtVemug%3D%3D Dragovic T, Schraufnagel DE, Becker RP, Sekosan M, Votta-Velis EG, Erdős EG (1995) Carboxypeptidase M activity is increased in bronchoalveolar lavage in human lung disease. Am J Respir Crit Care Med 152:760–764
8. EG Erdos PA Deddish 2002 The kinin system: suggestions to broaden some prevailing concepts Int Immunopharmacol 2 1741 1746 12489787 10.1016/S1567-5769(02)00166-2 1:CAS:528:DC%2BD38XovFGhtL8%3D Erdos EG, Deddish PA (2002) The kinin system: suggestions to broaden some prevailing concepts. Int Immunopharmacol 2:1741–1746
9. L Ferrer Soler J Cedano E Querol R Liorens de 2003 Cloning, expression and purification of human epidermal growth factor using different expression systems J Chromatogr B Analyt Technol Biomed Life Sci 788 113 123 12668077 10.1016/S1570-0232(02)01035-8 1:CAS:528:DC%2BD3sXjtlymtb4%3D Ferrer Soler L, Cedano J, Querol E, de Liorens R (2003) Cloning, expression and purification of human epidermal growth factor using different expression systems. J Chromatogr B Analyt Technol Biomed Life Sci 788:113–123
10. P Gogolak B Rethi I Szatmári A Lanyi B Dezso L Nagy E Rajnavolgyi 2007 Differentiation of CD1a− and CD1a+ monocyte-derived dendritic cells is biased by lipid enviroment and PPARγ Blood 109 641 652 10.1182/blood-2006-04-016840 1:CAS:528:DC%2BD2sXivVyrs74%3D Gogolak P, Rethi B, Szatmári I, Lanyi A, Dezso B, Nagy L, Rajnavolgyi E (2007) Differentiation of CD1a− and CD1a+ monocyte-derived dendritic cells is biased by lipid enviroment and PPARγ. Blood 109:641–652
11. RS Herbst D Prager R Herman 2005 TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced small cell lung cancer J Clin Oncol 23 5892 5899 16043829 10.1200/JCO.2005.02.840 1:CAS:528:DC%2BD2MXhtVKgtbzN Herbst RS, Prager D, Herman R et al (2005) TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced small cell lung cancer. J Clin Oncol 23:5892–5899
12. FR Hirsch M Varella-Garcia PA Bunn MV Di Maria R Veve RM Bremnes AE Baron C Zeng W Franklin 2003 Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 3798 3807 12953099 10.1200/JCO.2003.11.069 1:CAS:528:DC%2BD2cXpsVKisL8%3D Hirsch FR, Varella-Garcia M, Bunn PA, Di Maria MV, Veve R, Bremnes RM, Baron AE, Zeng C, Franklin W (2003) Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21:3798–3807
13. PC Hoffman AM Mauer EE Vokes 2000 Lung cancer Lancet 355 479 485 10841143 1:STN:280:DC%2BD3c3pslygug%3D%3D Hoffman PC, Mauer AM, Vokes EE (2000) Lung cancer. Lancet 355:479–485
14. MD Hollenberg H Gregorz 1980 Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives Mol Pharmacol 17 314 320 6248761 1:CAS:528:DyaL3cXktlOrtrw%3D Hollenberg MD, Gregorz H (1980) Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives. Mol Pharmacol 17:314–320
15. A Jemal T Murray A Samuels 2003 Cancer statistics CA-Cancer J Clin 53 5 26 12568441 10.3322/canjclin.53.1.5 Jemal A, Murray T, Samuels A (2003) Cancer statistics. CA-Cancer J Clin 53:5–26
16. K Kelly N Hanna A Rosenberg PA Bunn MN Needle 2003 Multicentered phase I/II study of cetuximab in combination with paclitaxel and carboplatin in untreated patients with stage IV non-small cell lung cancer Proc Am Soc Clin Oncol 22 644 644 Kelly K, Hanna N, Rosenberg A, Bunn PA, Needle MN (2003) Multicentered phase I/II study of cetuximab in combination with paclitaxel and carboplatin in untreated patients with stage IV non-small cell lung cancer. Proc Am Soc Clin Oncol 22:644–644
17. LMF Leeb-Lundberg F Marceau W Müller-Esterl DJ Pettibone BJ Zuraw 2005 International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol Rev 57 27 77 15734727 10.1124/pr.57.1.2 1:CAS:528:DC%2BD2MXis1Gmtr0%3D Leeb-Lundberg LMF, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BJ (2005) International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27–77
18. J Li M Rehli B Timblin F Tan SW Krause RA Skidgel 2002 Structure of the human carboxypeptidase M gene. Identification of a proximal GC-rich promoter and a unique distal promoter that consists of repetitive elements Gene 284 189 202 11891060 10.1016/S0378-1119(01)00898-8 1:CAS:528:DC%2BD38Xhslyls78%3D Li J, Rehli M, Timblin B, Tan F, Krause SW, Skidgel RA (2002) Structure of the human carboxypeptidase M gene. Identification of a proximal GC-rich promoter and a unique distal promoter that consists of repetitive elements. Gene 284:189–202
19. P Maione C Gridelli T Troiani F Ciardiello 2006 Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC Oncologist 11 274 284 16549812 10.1634/theoncologist.11-3-274 1:CAS:528:DC%2BD28XhtFKrtLnE Maione P, Gridelli C, Troiani T, Ciardiello F (2006) Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC. Oncologist 11:274–284
20. E Massarelli RS Herbst 2006 A novel second-line targeted therapies in non-small cell lung cancer Semin Oncol 33 S1 9 16 10.1053/j.seminoncol.2005.12.007 1:CAS:528:DC%2BD28XivVSgtLw%3D Massarelli E, Herbst RS (2006) A novel second-line targeted therapies in non-small cell lung cancer. Semin Oncol 33(S1):9–16
21. GB McGwire RA Skidgel 1995 Extracellular conversion of epidermal growth factor (EGF) to des-Arg 53-EGF by carboxypeptidase M J Biol Chem 270 17154 17158 7615511 10.1074/jbc.270.29.17154 1:CAS:528:DyaK2MXntVOrsLg%3D McGwire GB, Skidgel RA (1995) Extracellular conversion of epidermal growth factor (EGF) to des-Arg 53-EGF by carboxypeptidase M. J Biol Chem 270:17154–17158
22. GB McGwire RP Becker RA Skidgel 1999 Carboxypeptidase M, a glycosylphos-phatidylinositol-anchored protein, is localized on both the apical and the basolateral domains of polarized Madin-Darby Canine Kidney cells J Biol Chem 274 31632 31640 10531371 10.1074/jbc.274.44.31632 1:CAS:528:DyaK1MXntFOjs74%3D McGwire GB, Becker RP, Skidgel RA (1999) Carboxypeptidase M, a glycosylphos-phatidylinositol-anchored protein, is localized on both the apical and the basolateral domains of polarized Madin-Darby Canine Kidney cells. J Biol Chem 274:31632–31640
23. AP Meert B Martin P Delmotte 2001 The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis Eur Respir J 20 975 981 10.1183/09031936.02.00296502 Meert AP, Martin B, Delmotte P et al (2001) The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J 20:975–981
24. F Morgillo H-Y Lee 2005 Resistence to epidermal growth factor receptor-targeted therapy Drug Resist Updat 8 298 310 16172017 10.1016/j.drup.2005.08.004 1:CAS:528:DC%2BD2MXht1Oms7%2FE Morgillo F, Lee H-Y (2005) Resistence to epidermal growth factor receptor-targeted therapy. Drug Resist Updat 8:298–310
25. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 9187198 10.1378/chest.111.6.1710 1:STN:280:DyaK2szjtVOguw%3D%3D Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717
26. A Nagae M Abe RP Becker PA Deddish RA Skidgel EG Erdös 1993 High concentration of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells Am J Respir Cell Mol Biol 9 221 229 8338689 1:CAS:528:DyaK2cXhsF2ms78%3D Nagae A, Abe M, Becker RP, Deddish PA, Skidgel RA, Erdös EG (1993) High concentration of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol Biol 9:221–229
27. RI Nicholson JM Gee ME Harper 2001 EGFR and cancer prognosis Eur J Cancer 37/4 S9 S15 10.1016/S0959-8049(01)00231-3 Nicholson RI, Gee JM, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37/4:S9–S15
28. J Niemiec L Kolodziejski S Dyczek 2005 EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients Neoplasma 52 231 237 15875085 1:STN:280:DC%2BD2M3jslylsQ%3D%3D Niemiec J, Kolodziejski L, Dyczek S (2005) EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients. Neoplasma 52:231–237
29. N Normanno A Luca De C Bianco L Strizzi M Mancino M Maiello 2005 Epidermal growth factor receptor (EGFR) signalling in cancer Gene 366 2 16 16377102 10.1016/j.gene.2005.10.018 1:CAS:528:DC%2BD28Xht1Crs7k%3D Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello M et al (2005) Epidermal growth factor receptor (EGFR) signalling in cancer. Gene 366:2–16
30. Y Ohsaki S Tanno Y Fujita 2000 Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression Oncol Rep 7 603 607 10767376 1:CAS:528:DC%2BD3cXjtVOisr4%3D Ohsaki Y, Tanno S, Fujita Y et al (2000) Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 7:603–607
31. W Pao V Miller M Zakowski J Doherty 2004 EGF receptor gene mutations are common in lung cancers from “never smoker” and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci USA 101 13306 13311 15329413 10.1073/pnas.0405220101 1:CAS:528:DC%2BD2cXnvFems70%3D Pao W, Miller V, Zakowski M, Doherty J et al (2004) EGF receptor gene mutations are common in lung cancers from “never smoker” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306–13311
32. G Parries K Chen KS Misono S Cohen 1995 The human urinary epidermal growth factor (EGF) precursor J Biol Chem 270 27954 27960 7499272 10.1074/jbc.270.46.27954 1:CAS:528:DyaK2MXpsFShu7w%3D Parries G, Chen K, Misono KS, Cohen S (1995) The human urinary epidermal growth factor (EGF) precursor. J Biol Chem 270:27954–27960
33. LG Pessoa ID da Silva HA Baptista JL Pesquero AC Paiva M Bader JB Pesquero 2002 Molecular structure and alternative splicing of the human carboxypeptidase M gene Biol Chem 383 263 269 11934264 10.1515/BC.2002.028 1:CAS:528:DC%2BD38Xjt1eiurs%3D Pessoa LG, da Silva ID, Baptista HA, Pesquero JL, Paiva AC, Bader M, Pesquero JB (2002) Molecular structure and alternative splicing of the human carboxypeptidase M gene. Biol Chem 383:263–269
34. RK Rao O Koldovski M Kore PF Pollack S Wright TP Davis 1990 Processing and transfer of epidermal growth factor in developing jejunum and ileum Peptides 11 1093 1102 2087434 10.1016/0196-9781(90)90136-S 1:CAS:528:DyaK3MXnsFOmtw%3D%3D Rao RK, Koldovski O, Kore M, Pollack PF, Wright S, Davis TP (1990) Processing and transfer of epidermal growth factor in developing jejunum and ileum. Peptides 11:1093–1102
35. CA Renfrew AL Hubbard 1991 Sequential processing of epidermal growth factor in early and late endosomes of rat liver J Biol Chem 266 4348 4356 1671862 1:CAS:528:DyaK3MXhslyqtrY%3D Renfrew CA, Hubbard AL (1991) Sequential processing of epidermal growth factor in early and late endosomes of rat liver. J Biol Chem 266:4348–4356
36. D Reverter K Maskos F Tan RA Skidgel W Bode 2004 Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity J Mol Biol 338 257 269 15066430 10.1016/j.jmb.2004.02.058 1:CAS:528:DC%2BD2cXivVelt74%3D Reverter D, Maskos K, Tan F, Skidgel RA, Bode W (2004) Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J Mol Biol 338:257–269
37. V Rusch D Klimstra E Venkatraman 1997 Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression Clin Cancer Res 3 515 522 9815714 1:CAS:528:DyaK2sXislGitLk%3D Rusch V, Klimstra D, Venkatraman E et al (1997) Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 3:515–522
38. H Sasaki S Shimizu K Endo 2006 EGFR and erB2 mutation status in Japanese lung cancer patients Int J Cancer 118 180 184 16003726 10.1002/ijc.21301 1:CAS:528:DC%2BD2MXht1KgsrrE Sasaki H, Shimizu S, Endo K et al (2006) EGFR and erB2 mutation status in Japanese lung cancer patients. Int J Cancer 118:180–184
39. RP Schaudies CR Savage 1986 Intracellular modification of 125I-labeled epidermal growth factor by normal human foreskin fibroblasts Endocrinology 118 875 882 2867893 1:CAS:528:DyaL28XhtVeitr8%3D 10.1210/endo-118-2-875 Schaudies RP, Savage CR (1986) Intracellular modification of 125I-labeled epidermal growth factor by normal human foreskin fibroblasts. Endocrinology 118:875–882
40. G Selvaggi S Novello V Torri E Leonardo P Giuli De P Borasio C Mossetti F Ardissone P Lausi GV Scagliotti 2004 Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small cell lung cancer Ann Oncol 15 28 32 14679115 10.1093/annonc/mdh011 1:STN:280:DC%2BD3srps1Kntw%3D%3D Selvaggi G, Novello S, Torri V, Leonardo E, De Giuli P, Borasio P, Mossetti C, Ardissone F, Lausi P, Scagliotti GV (2004) Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small cell lung cancer. Ann Oncol 15:28–32
41. M Sitja-Arnau MA Molina C Blanco-Aparicio 2005 Mechanism of action of potato carboxypeptidase inhibitor (PCI) as an EGF blocker Cancer Lett 26 169 184 10.1016/j.canlet.2005.01.025 1:CAS:528:DC%2BD2MXmsVaitr0%3D Sitja-Arnau M, Molina MA, Blanco-Aparicio C et al (2005) Mechanism of action of potato carboxypeptidase inhibitor (PCI) as an EGF blocker. Cancer Lett 26:169–184
42. RA Skidgel EG Erdős 1998 Cellular carboxypeptidases Immunol Rev 161 129 141 9553770 10.1111/j.1600-065X.1998.tb01577.x 1:CAS:528:DyaK1cXitlymsL4%3D Skidgel RA, Erdős EG (1998) Cellular carboxypeptidases. Immunol Rev 161:129–141
43. RA Skidgel RM Davis F Tan 1989 Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones J Biol Chem 264 2236 2241 2914904 1:CAS:528:DyaL1MXhs1yrtrs%3D Skidgel RA, Davis RM, Tan F (1989) Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 264:2236–2241
44. RA Skidgel GB McGwire XY Li 1996 Membrane anchoring and release of carboxypeptidase M: implications for extracellular hydrolysis of peptide hormones Immunopharmacology 32 48 52 8796265 10.1016/0162-3109(96)00008-2 1:CAS:528:DyaK28XjsVOqt7w%3D Skidgel RA, McGwire GB, Li XY (1996) Membrane anchoring and release of carboxypeptidase M: implications for extracellular hydrolysis of peptide hormones. Immunopharmacology 32:48–52
45. RA Skidgel S Stanisavljevic EG Erdös 2006 Kinin-and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells Biol Chem 387 159 165 16497147 10.1515/BC.2006.021 1:CAS:528:DC%2BD28XitF2lsrg%3D Skidgel RA, Stanisavljevic S, Erdös EG (2006) Kinin-and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Biol Chem 387:159–165
46. B Sonnweber M Diaska S Skvortsov 2006 High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC) J Clin Pathol 59 255 259 16505275 10.1136/jcp.2005.027615 1:STN:280:DC%2BD287hslyktA%3D%3D Sonnweber B, Diaska M, Skvortsov S et al (2006) High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J Clin Pathol 59:255–259
47. MB Sporn AB Robert 1985 Autocrine growth factors and cancer Nature 313 745 747 3883191 10.1038/313745a0 1:CAS:528:DyaL2MXhsVKrur8%3D Sporn MB, Robert AB (1985) Autocrine growth factors and cancer. Nature 313:745–747
48. M Suzuki H Shigematsu T Lizasa 2006 Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer Cancer 106 2200 2207 16598760 10.1002/cncr.21853 1:CAS:528:DC%2BD28XkvFOnt7k%3D Suzuki M, Shigematsu H, Lizasa T et al (2006) Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer 106:2200–2207
49. I Szatmari P Gogolak SJ Im B Dezso 2004 Activation of PPARγ specifies a dendritic cell subtype capable of enhaced induction of iNKT cell expansion Immunity 21 95 106 15345223 10.1016/j.immuni.2004.06.003 1:CAS:528:DC%2BD2cXmtlKjt78%3D Szatmari I, Gogolak P, Im SJ, Dezso B et al (2004) Activation of PPARγ specifies a dendritic cell subtype capable of enhaced induction of iNKT cell expansion. Immunity 21:95–106
50. I Szatmari A Pap R Rühl JX Ma E Rajnavolgyi B Dezso L Nagy 2006 PPAR-gamma controls CD1d expression by turning on retionic acid synthesis in developing human dendritic cell J Exp Med 203 2351 2362 16982809 10.1084/jem.20060141 1:CAS:528:DC%2BD28XhtVGlsL7K Szatmari I, Pap A, Rühl R, Ma JX, Rajnavolgyi E, Dezso B, Nagy L (2006) PPAR-gamma controls CD1d expression by turning on retionic acid synthesis in developing human dendritic cell. J Exp Med 203:2351–2362